Physician
Sleeper, Kristin
Sleeper, Kristin was paid $267K by Medicaid between Dec 2018 and Mar 2023, across 15 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 36% of everything it billed.
33Billing provider infoSLEEPER, KRISTIN
PEABODY, MA 01960
PEABODY, MA 01960
33aNPI1386674141assigned 07/04/2006
33bProvider typePediatrics Physician
28Total paid$267K
24GClaims5,630
24DCodes billed15
24AFirst – last monthDec 2018 – Mar 2023
Compared with peers
Next to other Pediatrics Physician providers in Massachusetts
Rank by total paid#237 of 1,273
Median peer was paid$24K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 30 | $2K | |
| 2019 | 222 | $13K | |
| 2020 | 848 | $40K | |
| 2021 | 2,436 | $104K | |
| 2022 | 1,804 | $92K | |
| 2023 | 290 | $16K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 36% | 1,642 | 1,628 | $96K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 24% | 640 | 635 | $65K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 17% | 878 | 870 | $45K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 6.9% | 733 | 724 | $18K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 5.8% | 191 | 190 | $15K |
| 99050 | 3.0% | 493 | 488 | $8K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.6% | 195 | 194 | $7K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.2% | 191 | 190 | $6K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | <1% | 253 | 253 | $2K |
| 0071A | <1% | 30 | 30 | $1K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 70 | 70 | $718.90 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 33 | 33 | $674.85 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.